Mammary gland neoplasia: insights from transgenic mouse models

被引:0
|
作者
Siegel, PM
Hardy, WR
Muller, WJ [1 ]
机构
[1] McMaster Univ, Inst Mol Biol & Biotechnol, Hamilton, ON, Canada
[2] McMaster Univ, Dept Biol, Hamilton, ON, Canada
[3] McMaster Univ, Dept Biochem, Hamilton, ON, Canada
[4] McMaster Univ, Dept Pathol & Mol Med, Hamilton, ON, Canada
关键词
D O I
10.1002/(SICI)1521-1878(200006)22:6<554::AID-BIES8>3.0.CO;2-A
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Current theories of breast cancer progression have been greatly influenced by the development and refinement of mouse transgenic and gene targeting technologies. Early transgenic mouse models confirmed the involvement of oncogenes, previously implicated in human breast cancer, by establishing a causal relationship between overexpression or activation of these genes and mammary tumorigenesis. More recently, the importance of genes located at sites of loss of heterozygosity in human breast cancer have been examined in mice by their targeted disruption via homologous recombination, The union of these two approaches allows the generation of complex animal models that more accurately reflect the multistep nature of human breast cancer. This review will examine how the study of transgenic mice has increased our understanding of the molecular events responsible for oncogenic transformation of the mammary gland. BioEssays 22:554-583, 2000, (C) 2000 John Wiley & Sons, Inc.
引用
收藏
页码:554 / 563
页数:10
相关论文
共 50 条
  • [11] Transcriptomic signature of Bexarotene (Rexinoid LGD1069) on mammary gland from three transgenic mouse mammary cancer models
    Martin C Abba
    Yuhui Hu
    Carla C Levy
    Sally Gaddis
    Frances S Kittrell
    Yun Zhang
    Jamal Hill
    Reid P Bissonnette
    Daniel Medina
    Powel H Brown
    C Marcelo Aldaz
    BMC Medical Genomics, 1
  • [12] Transcriptomic signature of Bexarotene (Rexinoid LGD1069) on mammary gland from three transgenic mouse mammary cancer models
    Abba, Martin C.
    Hu, Yuhui
    Levy, Carla C.
    Gaddis, Sally
    Kittrell, Frances S.
    Zhang, Yun
    Hill, Jamal
    Bissonnette, Reid P.
    Medina, Daniel
    Brown, Powel H.
    Aldaz, C. Marcelo
    BMC MEDICAL GENOMICS, 2008, 1 (1)
  • [13] Transgenic models to study actions of prolactin in mammary neoplasia
    Arendt, Lisa M.
    Schuler, Linda A.
    JOURNAL OF MAMMARY GLAND BIOLOGY AND NEOPLASIA, 2008, 13 (01) : 29 - 40
  • [14] Transgenic Models to Study Actions of Prolactin in Mammary Neoplasia
    Lisa M. Arendt
    Linda A. Schuler
    Journal of Mammary Gland Biology and Neoplasia, 2008, 13 : 29 - 40
  • [15] Mammary gland neoplasia
    Neumann, DA
    Crisp, TM
    Olin, SS
    ENVIRONMENTAL HEALTH PERSPECTIVES, 1996, 104 (09) : 912 - 914
  • [16] A Transgenic MMTV-Flippase Mouse Line for Molecular Engineering in Mammary Gland and Breast Cancer Mouse Models
    Luond, Fabiana
    Bill, Ruben
    Vettiger, Andrea
    Oller, Heide
    Pelczar, Pawel
    Christofori, Gerhard
    JOURNAL OF MAMMARY GLAND BIOLOGY AND NEOPLASIA, 2019, 24 (01) : 39 - 45
  • [17] A Transgenic MMTV-Flippase Mouse Line for Molecular Engineering in Mammary Gland and Breast Cancer Mouse Models
    Fabiana Lüönd
    Ruben Bill
    Andrea Vettiger
    Heide Oller
    Pawel Pelczar
    Gerhard Christofori
    Journal of Mammary Gland Biology and Neoplasia, 2019, 24 : 39 - 45
  • [18] IGF and Insulin Action in the Mammary Gland: Lessons from Transgenic and Knockout Models
    Darryl L. Hadsell
    Sharon G. Bonnette
    Journal of Mammary Gland Biology and Neoplasia, 2000, 5 : 19 - 30
  • [19] IGF and insulin action in the mammary gland: Lessons from transgenic and knockout models
    Hadsell, DL
    Bonnette, SG
    JOURNAL OF MAMMARY GLAND BIOLOGY AND NEOPLASIA, 2000, 5 (01) : 19 - 30
  • [20] Genetically Engineered Mouse Models of Mammary Intraepithelial Neoplasia
    Robert D. Cardiff
    Drew Moghanaki
    Roy A. Jensen
    Journal of Mammary Gland Biology and Neoplasia, 2000, 5 : 421 - 437